Skip to content
Cryptenamine acetates
Unitensen (cryptenamine acetates) is a small molecule pharmaceutical. Cryptenamine acetates was first approved as Unitensen on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Cryptenamine acetates
Tradename
Company
Number
Date
Products
UNITENSENMedpointe Pharm HlcN-008814 DISCN1982-01-01
1 products
Hide discontinued
Cryptenamine tannates
Tradename
Company
Number
Date
Products
UNITENSENMedpointe Pharm HlcN-009217 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCRYPTENAMINE ACETATES
INN
Description
Cryptenamine (Unitensen) is a mixture of 10 hypotensive alkaloids extracted from Veratrum album (protoveratrines A and B; germitrine, neogermitrine, germerine, and germidine; jervine, rubijervine, and isorubijervine; and germbudine). It is used in the treatment of hypertension.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID1356-18-9
RxCUI42618
ChEMBL IDCHEMBL1201444
ChEBI ID
PubChem CID
DrugBankDB00785
UNII ID
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 2 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
240 adverse events reported
View more details